Literature DB >> 11713233

Aberrant growth plate development in VDR/RXR gamma double null mutant mice.

N Yagishita1, Y Yamamoto, T Yoshizawa, K Sekine, Y Uematsu, H Murayama, Y Nagai, W Krezel, P Chambon, T Matsumoto, S Kato.   

Abstract

VDR forms heterodimers with one of three RXRs, RXR alpha, RXR beta, and RXR gamma, and it is thought that RXR ligands can also modulate the trans-activation function of VDR/RXR heterodimers. In the present study we generated VDR/RXR gamma double null mutant mice to examine the convergent actions of vitamin D and vitamin A signaling and to explore the possibility of a functionally redundant VDR. Although RXR gamma(-/-) mice exhibited no overt abnormalities, VDR(-/-)/RXR gamma(-/-) mice appeared similar to VDR(-/-) mice, showing features typical of vitamin D-dependent rickets type II, including growth retardation, impaired bone formation, hypocalcemia, and alopecia. However, compared to VDR(-/-) mice, growth plate development in VDR(-/-)/RXR gamma(-/-) mutant mice was more severely impaired. Normalizing mineral ion homeostasis through dietary supplementation with high calcium and phosphorous effectively prevented rachitic abnormalities, except for disarranged growth plates in VDR(-/-)/RXR gamma(-/-) mutant mice, and alopecia in both VDR(-/-) and VDR(-/-)/RXR gamma(-/-) mutant mice. Histological analysis of VDR(-/-)/RXR gamma(-/-) growth plates revealed that development of the hypertrophic chondrocytes was selectively impaired. Thus, our findings indicated that the combined actions of VDR- and RXR gamma-mediated signals are essential for the normal development of growth plate chondrocytes, and raised the possibility that a functionally redundant VDR is present on chondrocytes as a heterodimer with RXR gamma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713233     DOI: 10.1210/endo.142.12.8544

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

2.  Chondromodulin I is a bone remodeling factor.

Authors:  Yuko Nakamichi; Chisa Shukunami; Takashi Yamada; Ken-ichi Aihara; Hirotaka Kawano; Takashi Sato; Yuriko Nishizaki; Yoko Yamamoto; Masayo Shindo; Kimihiro Yoshimura; Takashi Nakamura; Naoyuki Takahashi; Hiroshi Kawaguchi; Yuji Hiraki; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix.

Authors:  Masatoshi Fukuda; Tatsuya Yoshizawa; Md Fazlul Karim; Shihab U Sobuz; Wataru Korogi; Daiki Kobayasi; Hiroki Okanishi; Masayoshi Tasaki; Katsuhiko Ono; Tomohiro Sawa; Yoshifumi Sato; Mami Chirifu; Takeshi Masuda; Teruya Nakamura; Hironori Tanoue; Kazuhisa Nakashima; Yoshihiro Kobashigawa; Hiroshi Morioka; Eva Bober; Sumio Ohtsuki; Yuriko Yamagata; Yukio Ando; Yuichi Oike; Norie Araki; Shu Takeda; Hiroshi Mizuta; Kazuya Yamagata
Journal:  Nat Commun       Date:  2018-07-19       Impact factor: 14.919

4.  Exposure to the RXR Agonist SR11237 in Early Life Causes Disturbed Skeletal Morphogenesis in a Rat Model.

Authors:  Holly Dupuis; Michael Andrew Pest; Ermina Hadzic; Thin Xuan Vo; Daniel B Hardy; Frank Beier
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

5.  A Novel Inhibitor INF 39 Promotes Osteogenesis via Blocking the NLRP3/IL-1β Axis.

Authors:  Wenxiang Chen; Pan Tang; Shunwu Fan; Xuesheng Jiang
Journal:  Biomed Res Int       Date:  2022-07-13       Impact factor: 3.246

6.  Interaction between allelic variations in vitamin D receptor and retinoid X receptor genes on metabolic traits.

Authors:  Karani S Vimaleswaran; Alana Cavadino; Diane J Berry; Massimo Mangino; Peter Andrews; Jason H Moore; Timothy D Spector; Chris Power; Marjo-Riitta Järvelin; Elina Hyppönen
Journal:  BMC Genet       Date:  2014-03-19       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.